Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma

Blood. 2009 Jun 4;113(23):5938-41. doi: 10.1182/blood-2008-09-179168. Epub 2009 Feb 27.

Abstract

The presence of tumor-specific microRNAs reflects tissue of origin and tumor stage. We show that the absence of miRNAs likewise can be used to determine tumor origin (miR-155) and proliferation state because tumor suppressor miRNAs (miR-222/221, let-7 family) were significantly down-regulated in primary effusion lymphoma (PEL) and in Kaposi sarcoma (KS), an endothelial cell tumor. PEL and KS are associated with KS-associated herpesvirus infection. We identified 15 virally regulated miRNAs in latently infected, nontumorigenic endothelial cells. MiR-143/145 were elevated only in KS tumors, not virally infected endothelial cells. Thus, they represent tumor-specific, rather than virus-specific, miRNAs. Because many tumor suppressor proteins are wild-type in KS and PEL, down-regulation of multiple tumor suppressor miRNAs provides a novel, alternative mechanism of transformation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Profiling
  • Genes, Tumor Suppressor*
  • Lymphoma, Primary Effusion / genetics*
  • MicroRNAs / genetics*
  • Sarcoma, Kaposi / genetics*

Substances

  • MicroRNAs